Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 252


Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.

Chen R, Zinzani PL, Lee HJ, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Lin J, Kim E, Nahar A, Balakumaran A, Moskowitz CH.

Blood. 2019 Oct 3;134(14):1144-1153. doi: 10.1182/blood.2019000324. Epub 2019 Aug 13.


Oxidants Regulated Diaphragm Proteolysis during Mechanical Ventilation in Rats.

Moroz N, Maes K, Leduc-Gaudet JP, Goldberg P, Petrof BJ, Mayaki D, Vassilakopoulos T, Rassier D, Gayan-Ramirez G, Hussain SN.

Anesthesiology. 2019 Sep;131(3):605-618. doi: 10.1097/ALN.0000000000002837.


Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group.

Papageorgiou SG, Kontos CK, Kotsianidis I, Karousi P, Symeonidis A, Galanopoulos A, Bouchla A, Hatzimichael E, Repousis P, Zikos P, Viniou NA, Poulakidas E, Vassilakopoulos TP, Diamantopoulos P, Mparmparousi D, Bouronikou E, Papadaki H, Panayiotidis P, Pappa V.

J Geriatr Oncol. 2019 Jul 27. pii: S1879-4068(19)30111-0. doi: 10.1016/j.jgo.2019.07.018. [Epub ahead of print] No abstract available.


Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies.

Vassilakopoulos TP, Chatzidimitriou C, Asimakopoulos JV, Arapaki M, Tzoras E, Angelopoulou MK, Konstantopoulos K.

Cancers (Basel). 2019 Jul 29;11(8). pii: E1071. doi: 10.3390/cancers11081071. Review.


Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS).

Kotsianidis I, Papageorgiou SG, Pappa V, Galanopoulos AG, Viniou NA, Vassilakopoulos TP, Papoutselis M, Vrachiolias G, Papadopoulos V, Diamantopoulos PT, Tsokanas D, Kourakli A, Symeonidis A.

Mediterr J Hematol Infect Dis. 2019 Jul 1;11(1):e2019045. doi: 10.4084/MJHID.2019.045. eCollection 2019. No abstract available.


A Unique Case of Primary Extranodal Marginal Zone Lymphoma of the Anal Canal.

Diamantopoulos P, Dryllis G, Tsourouflis G, Petevi K, Boutsikas G, Rondogianni P, Boutsis D, Korkolopoulou P, Konstantopoulos K, Angelopoulou MK, Meletis J, Kanellis G, Vassilakopoulos TP.

Acta Haematol. 2019;142(2):87-91. doi: 10.1159/000495601. Epub 2019 Jun 17.


Safety and efficacy analysis of long-term follow up real-world data with ibrutinib monotherapy in 58 patients with CLL treated in a single-center in Greece.

Dimou M, Iliakis T, Pardalis V, Bitsani C, Vassilakopoulos TP, Angelopoulou M, Tsaftaridis P, Papaioannou P, Koudouna A, Kalyva S, Kyrtsonis MC, Panayiotidis P.

Leuk Lymphoma. 2019 Jun 11:1-7. doi: 10.1080/10428194.2019.1620944. [Epub ahead of print]


Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in "Real-Life" Outside of Clinical Trials.

Sachanas S, Pangalis GA, Fink AM, Bahlo J, Fischer K, Levidou G, Kyrtsonis MC, Bartzi V, Vassilakopoulos TP, Kalpadakis C, Koulieris E, Moschogiannis M, Yiakoumis X, Tsirkinidis P, Angelopoulou MK, Eichhorst B, Hallek M.

Anticancer Res. 2019 May;39(5):2591-2598. doi: 10.21873/anticanres.13382.


Regulation of breathing pattern by IL-10.

Giannakopoulou CE, Sotiriou A, Dettoraki M, Yang M, Perlikos F, Toumpanakis D, Prezerakos G, Koutsourelakis I, Kastis GA, Vassilakopoulou V, Mizi E, Papalois A, Greer JJ, Vassilakopoulos T.

Am J Physiol Regul Integr Comp Physiol. 2019 Jul 1;317(1):R190-R202. doi: 10.1152/ajpregu.00065.2019. Epub 2019 May 15.


Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome.

Diamantopoulos PT, Kontandreopoulou CN, Symeonidis A, Kotsianidis I, Pappa V, Galanopoulos A, Vassilakopoulos T, Dimou M, Solomou E, Kyrtsonis MC, Siakantaris M, Angelopoulou M, Kourakli A, Papageorgiou S, Christopoulou G, Roumelioti M, Panayiotidis P, Viniou NA; Hellenic MDS Study Group.

Ann Hematol. 2019 Jun;98(6):1383-1392. doi: 10.1007/s00277-019-03650-w. Epub 2019 Mar 15.


Detection of CALR Mutations Using High Resolution Melting Curve Analysis (HRM-A); Application on a Large Cohort of Greek ET and MF Patients.

Giannopoulos A, Rougkala N, Loupis T, Mantzourani M, Viniou NA, Variami E, Vassilakopoulos TP, Dryllis G, Kotsianidis I, Gougopoulou T, Politou M, Konstantopoulos K, Vassilopoulos G.

Mediterr J Hematol Infect Dis. 2019 Jan 1;11(1):e2019009. doi: 10.4084/MJHID.2019.009. eCollection 2019.


Central nervous system involvement in primary bone marrow or splenic marginal zone lymphoma: Report of two cases and review of the literature.

Angelopoulou MK, Vassilakopoulos TP, Konstantinou E, Boutsikas G, Asimakopoulos JV, Triantafyllou EF, Petevi K, Kanellopoulos A, Moschogiannis M, Pangalis GA, Siakantaris MP, Konstantopoulos K.

Hematol Oncol. 2019 Apr;37(2):219-222. doi: 10.1002/hon.2571. Epub 2019 Feb 1. Review. No abstract available.


Prediction of dysnatremias in critically ill patients based on the law of conservation of mass. Comparison of existing formulae.

Katsiampoura A, Toumpanakis D, Konsta K, Varkaris A, Vassilakopoulos T.

PLoS One. 2018 Nov 26;13(11):e0207603. doi: 10.1371/journal.pone.0207603. eCollection 2018.


Diagnostic role of cytology in serous effusions of patients with hematologic malignancies.

Savvidou K, Dimitrakopoulou A, Kafasi N, Konstantopoulos K, Vassilakopoulos T, Angelopoulou M, Siakantaris M, Korkolopoulou P, Kanavaros P, Mikou P.

Diagn Cytopathol. 2019 May;47(5):404-411. doi: 10.1002/dc.24110. Epub 2018 Nov 12.


The Economic Burden of Chronic Obstructive Pulmonary Disease in Greece.

Kourlaba G, Hillas G, Vassilakopoulos T, Maniadakis N.

Appl Health Econ Health Policy. 2019 Feb;17(1):111-121. doi: 10.1007/s40258-018-0431-5.


Non-Inherited Maternal Antigens Identify Acceptable HLA Mismatches: A New Policy for the Hellenic Cord Blood Bank.

Panagouli E, Dinou A, Mallis P, Michalopoulos E, Papassavas A, Spyropoulou-Vlachou M, Meletis J, Angelopoulou M, Konstantopoulos K, Vassilakopoulos T, Stavropoulos-Giokas C.

Bioengineering (Basel). 2018 Sep 21;5(4). pii: E77. doi: 10.3390/bioengineering5040077.


The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.

Papageorgiou SG, Kontos CK, Kotsianidis I, Vasilatou D, Symeonidis A, Galanopoulos A, Bouchla A, Hatzimichael E, Repousis P, Zikos P, Viniou NA, Poulakidas E, Vassilakopoulos TP, Diamantopoulos P, Diamantopoulos MA, Mparmparousi D, Bouronikou E, Papadaki H, Panayiotidis P, Pappa V.

Hematol Oncol. 2018 Oct;36(4):693-700. doi: 10.1002/hon.2551. Epub 2018 Sep 7.


Senescence and senotherapeutics: a new field in cancer therapy.

Myrianthopoulos V, Evangelou K, Vasileiou PVS, Cooks T, Vassilakopoulos TP, Pangalis GA, Kouloukoussa M, Kittas C, Georgakilas AG, Gorgoulis VG.

Pharmacol Ther. 2019 Jan;193:31-49. doi: 10.1016/j.pharmthera.2018.08.006. Epub 2018 Aug 16. Review.


Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group.

Papageorgiou SG, Kotsianidis I, Kontos CK, Symeonidis A, Galanopoulos A, Hatzimichael E, Poulakidas E, Diamantopoulos P, Vassilakopoulos TP, Zikos P, Papadaki H, Bouronikou E, Panayiotidis P, Viniou NA, Pappa V.

Leuk Res. 2018 Aug;71:55-59. doi: 10.1016/j.leukres.2018.07.004. Epub 2018 Jul 7. No abstract available.


p38 Inhibition Ameliorates Inspiratory Resistive Breathing-Induced Pulmonary Inflammation.

Toumpanakis D, Vassilakopoulou V, Mizi E, Chatzianastasiou A, Loverdos K, Vraila I, Perlikos F, Tsoukalas D, Giannakopoulou CE, Sotiriou A, Dettoraki M, Karavana V, Vassilakopoulos T.

Inflammation. 2018 Oct;41(5):1873-1887. doi: 10.1007/s10753-018-0831-6.


Supplemental Content

Loading ...
Support Center